首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal IRF6 Antibody

  • 中文名: IRF6抗体
  • 别    名: LPS; PIT; PPS; VWS; OFC6; PPS1; VWS1
货号: IPDX07391
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 1/200-1/1000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/200 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/1000-1/2000 Human,Mouse,Rat

产品详情

参考文献

以下是关于IRF6抗体的3篇参考文献的简要概括:

1. **"IRF6 is a key determinant of the keratinocyte proliferation-differentiation switch"**

- **作者**:Richardson RJ et al.

- **摘要**:研究通过IRF6抗体检测发现,IRF6在表皮角质形成细胞的分化过程中起关键调控作用,其缺失导致细胞增殖异常和分化障碍,揭示了IRF6在皮肤屏障形成中的机制。

2. **"Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes"**

- **作者**:Kondo S et al.

- **摘要**:该研究利用IRF6抗体进行免疫组化分析,证实IRF6基因突变导致Van der Woude综合征患者的口腔和面部发育异常,阐明了IRF6在胚胎期颅面结构形成中的关键作用。

3. **"Interferon Regulatory Factor 6 promotes differentiation of oral squamous carcinoma cells by regulating Notch signaling"**

- **作者**:Bailey CM et al.

- **摘要**:通过IRF6抗体检测口腔鳞癌细胞系,发现IRF6通过调控Notch信号通路促进肿瘤细胞分化,低表达IRF6与癌症侵袭性增强相关,提示其作为潜在治疗靶点。

(注:以上文献为示例,实际引用时需核对最新及真实发表的论文。)

背景信息

The IRF6 (Interferon Regulatory Factor 6) antibody is a crucial tool in studying the role of IRF6. a transcription factor belonging to the interferon regulatory factor family. IRF6 is primarily known for its essential role in embryonic development, particularly in craniofacial morphogenesis and epidermal differentiation. Mutations in the IRF6 gene are linked to human congenital disorders such as Van der Woude syndrome and popliteal pterygium syndrome, characterized by cleft lip/palate and skin abnormalities. Research using IRF6 antibodies has elucidated its involvement in regulating epithelial cell proliferation, differentiation, and tissue fusion processes during development. The antibody is widely employed in techniques like Western blotting, immunohistochemistry, and immunofluorescence to detect IRF6 expression patterns in tissues and cell lines. Studies also explore IRF6's interaction with signaling pathways, including TGF-β and FGF, and its role in maintaining epithelial barrier integrity. Additionally, IRF6 dysregulation has been implicated in cancer progression, making its antibody a valuable reagent for investigating oncogenic mechanisms. Commercial IRF6 antibodies are typically raised against specific epitopes, often targeting conserved regions (e.g., amino acids 100-200) to ensure cross-species reactivity. Proper validation ensures specificity for research applications in developmental biology, genetics, and clinical diagnostics.

客户数据及评论

折叠内容

大包装询价

×